• MARCH5 Ubiquitin Ligase Controls Mitochondria-Derived Pre-Pe

  2026-06-30

  Zheng et al. (2025) identify the ubiquitin ligase MARCH5 as a pivotal regulator of mitochondria-derived pre-peroxisome formation, specifically mediating the budding of PEX3-containing vesicles. This work advances understanding of organelle interplay in peroxisome biogenesis and opens new avenues for mitochondrial biology research.

• L-NMMA Acetate: NOS Pathway Modulation for Regenerative Rese

  2026-06-30

  L-NMMA acetate enables precise, reproducible modulation of nitric oxide signaling, supporting advanced studies in inflammation, regeneration, and cardiovascular disease. Discover protocol-driven workflows, troubleshooting tactics, and insights from recent breakthroughs that position this pan-NOS inhibitor as a gold-standard research tool.

• Nanoparticle Surface Properties Enhance Ocular Drug Uptake

  2026-06-29

  This study dissects how the physicochemical properties of polymeric nanoparticles—specifically size and surface chemistry—shape their uptake by human corneal epithelial cells. The findings inform the rational design of ocular drug delivery systems that overcome corneal barriers and improve local bioavailability.

• Cy3 NHS Ester (Non-Sulfonated): Technical Guide and Workflow

  2026-06-29

  Cy3 NHS ester (non-sulfonated) offers a robust solution for fluorescent labeling of proteins, peptides, and oligonucleotides in workflows that tolerate organic co-solvents. Its high extinction coefficient and orange emission enable sensitive detection, but it is unsuitable for labeling delicate proteins in strictly aqueous conditions. Researchers should follow recommended protocols to ensure labeling efficiency and avoid solubility-related pitfalls.

• Capecitabine in Assembloid Models: Mechanism to Strategy

  2026-06-28

  This article explores Capecitabine’s tumor-selective activation, mechanistic pathways—including apoptosis via Fas-dependent signaling—and its strategic integration into next-generation assembloid models mimicking the tumor microenvironment. By bridging recent evidence from patient-derived gastric cancer assembloid research with actionable protocol recommendations, it provides translational researchers with a roadmap for deploying Capecitabine in preclinical oncology, advancing both mechanistic insight and experimental precision.

• Tetrahedral DNA Frameworks Enhance Enzymatic DNA Synthesis

  2026-06-27

  The reference study introduces a nanoscopic tetrahedral DNA framework (TDN) that organizes primers for more efficient enzymatic oligonucleotide synthesis (EOS). This structural advance improves enzyme accessibility, reduces error rates, and enables high-yield, accurate DNA synthesis, with implications for DNA data storage and advanced labeling strategies.

• BMS-777607: Unraveling MET Signaling for Translational Impac

  2026-06-26

  This thought-leadership article explores the mechanistic depth and translational opportunities of BMS-777607, a potent c-Met inhibitor, in both oncology and stem cell-based research. Integrating recent advances in small-molecule-facilitated platelet differentiation and cancer metastasis models, we offer actionable protocol insights, cross-domain relevance, and strategic guidance for translational scientists.

• Pregnancy Zone Protein Activates BAT Thermogenesis in IF Mod

  2026-06-26

  This study identifies pregnancy zone protein (PZP) as a hepatokine that mediates diet-induced thermogenesis by activating brown adipose tissue (BAT) during intermittent fasting. Mechanistic insights show PZP's interaction with GRP78 and induction of UCP1 via the p38 MAPK-ATF2 axis, offering a novel endocrine pathway for obesity intervention.

• Reserpine (SKU N1867): Technical Parameters for Research Use

  2026-06-25

  Reserpine (SKU N1867) is a high-purity research reagent suited for controlled studies of neurotransmitter depletion, antihypertensive mechanisms, and neuropharmacology workflows. It is not intended for diagnostic, clinical, or veterinary applications, and requires precise handling and storage to ensure reproducibility.

• 2-NBDG Glucose Uptake Assay Kit: Precision for Metabolism Re

  2026-06-25

  The 2-NBDG Glucose Uptake Assay Kit offers rapid, non-radioactive, and highly sensitive quantification of glucose uptake at the single-cell level—crucial for dissecting metabolic reprogramming in cancer and diabetes studies. Its integrated specificity control, streamlined workflow, and compatibility with high-throughput screening deliver a significant advantage over traditional glucose uptake assays.

• Dextromethorphan Hydrobromide: NMDA Antagonist in Neuroprote

  2026-06-24

  Dextromethorphan hydrobromide stands out as a high-purity NMDA receptor antagonist ideal for neuroprotection and excitotoxicity inhibition research. This article dissects practical workflows, advanced assay strategies, and troubleshooting insights, empowering neuroscientists to maximize reproducibility and translational impact with APExBIO’s trusted reagent.

• Cholesterol as a Principal Sterol in Advanced mRNA-LNP Resea

  2026-06-23

  Cholesterol’s unique biophysical properties underpin the stability and efficacy of lipid nanoparticles for mRNA delivery, especially in localized cancer therapy. This article unpacks the experimental workflows, key innovations, and troubleshooting insights using APExBIO’s high-purity cholesterol for cutting-edge membrane and nanoparticle studies.

• Targeting Cdc42 to Mitigate Kidney Fibrosis via β-Catenin Pa

  2026-06-23

  This study identifies the small molecule daphnepedunin A as a potent anti-fibrotic agent that directly inhibits Cdc42 activity, thereby suppressing kidney fibrosis through modulation of the GSK-3β/β-catenin pathway. The findings highlight Cdc42 as a promising therapeutic target for chronic kidney disease and provide a mechanistic basis for selective Cdc42 inhibition strategies.

• Cy3 NHS Ester (Non-Sulfonated): Technical Guide for Protein

  2026-06-22

  Cy3 NHS ester (non-sulfonated) addresses the need for precise, high-sensitivity fluorescent labeling of amino groups in proteins, peptides, and oligonucleotides, especially in workflows accepting organic co-solvents. It is not recommended for protocols requiring aqueous-only conditions or for storage as long-term dye solutions.

• Cholesterol as Principal Sterol in Lipid Nanoparticle Workfl

  2026-06-22

  Cholesterol, the principal sterol, is indispensable for engineering high-performance lipid nanoparticles (LNPs) in mRNA-based therapeutics. This article bridges benchwork protocols to translational applications, focusing on workflow optimizations, troubleshooting, and actionable insights from the latest bladder cancer research.

16116 records 1/1075 page Next 12345 下5页 Last page